16 results
Summary of dosing recommendations in renal impairment of commonly used hypoglycaemic agents

#Diabetes #Diabetic #Medications #Pharmacology #Dosing
hypoglycaemic agents #Diabetes ... #Diabetic #Medications ... #Pharmacology # ... Dosing #Dosing # ... Impairment #CKD #Table
Insulin and analogues onset of action, peak times and duration.

Follow at www.instagram.com/rxnotes for more!

#pharmacology #table #comparison
#pharmacology #table ... #comparison #dosing ... #insulin #diabetes
Metformin Treatment in Patients With Type 2 Diabetes and Chronic Kidney Disease Stages 3A, 3B, or
Patients With Type 2 Diabetes ... 3A, 3B, or 4 Diabetes ... Metformin #CKD3 #CKD4 #Dosing ... #Pharmacology # ... VisualAbstract #Nephrology
Algorithm for Metformin Prescribing and Dosing in CKD
Dose Initiation - Immediate release:
 • Initial 500 mg
Algorithm for Metformin ... Prescribing and Dosing ... #Prescribing #Dosing ... #CKD #pharmacology ... #algorithm #diabetes
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
#management #algorithm ... #pharmacology # ... #medications #table ... hematology #warfarin #dosing
Phosphate binders - quick reference chart of maximum daily dose. Most patients with CKD will require
since they are not able ... Only* #CKD #Nephrology ... Hyperphosphatemia #Dose #Dosing ... #Pharmacology #
LABA/ICS Combination Inhalers
Long-Acting Beta2 Agonists (LABA) + Inhaled Corticosteroid (ICS) - Commonly used in Asthma 
Advair
LABA/ICS Combination ... Corticosteroid (ICS ... COPD treatment algorithm ... are the normal dosing ... Naming #Names #Pharmacology
Hyperkalemia - Differential Diagnosis Framework

PseudoHyperkalemia:
 • Lab error
 • Traumatic venipuncture
 • Hemolysis, thrombocytosis, leukocytosis
 •
Clenching of fist during ... • NSAIDs • ACE ... (Uncontrolled diabetes ... potassium #high #nephrology
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
dependent DM ACS ... algorithm to determine ... Stable patients ... Diabetes regimen ... • <12mo since ACS
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Therapy (LAMA/LABA/ICS ... Eosinophils < 100 Dosing ... : 250 mcg tablet ... low, adding an ICS ... #Indications #Pharmacology